GE HealthCare tops Q4 profit estimates, offers full-year guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
GE HealthCare (GEHC) PT Raised to $110 at Jefferies
February 13, 2025 4:30 PM ESTJefferies analyst Matthew Taylor raised the price target on GE HealthCare (NASDAQ: GEHC) to $110.00 (from $103.00) while maintaining a Buy rating.
The analyst comments "GEHC reported 4Q sales of $5.32B, +2% xfx (+4% ex-China) vs cons $5.32B, & EPS of $1.45 +23% vs cons $1.26. Orders... More
GE HealthCare (GEHC) PT Raised to $104 at Stifel
February 13, 2025 2:45 PM ESTStifel analyst Rick Wise raised the price target on GE HealthCare (NASDAQ: GEHC) to $104.00 (from $102.00) while maintaining a Buy rating.
The analyst comments "Following the GEHC 4Q24 call, we came away feeling encouraged about the companys 4Q24 performance and initial 2025... More
GE HealthCare (GEHC) PT Raised to $110 at Citi
February 13, 2025 2:15 PM ESTCiti analyst Joanne Wuensch raised the price target on GE HealthCare (NASDAQ: GEHC) to $110.00 (from $103.00) while maintaining a Buy rating.
The analyst comments "There was a lot to the 4Q24 against relatively low expectations, with the top-line reflecting continued pressures in China, and... More
GE HealthCare (GEHC) PT Raised to $103 at BTIG
February 13, 2025 11:38 AM ESTBTIG analyst Ryan Zimmerman raised the price target on GE HealthCare (NASDAQ: GEHC) to $103.00 (from $99.00) while maintaining a Buy rating.
The analyst comments "We maintain our Buy and raise our PT to $103 (from $99) following GEHC's 4Q24 results. Rev. of $5.319B (2.0% Y/Y, 2.0% Y/Y organic) and adj. EPS of $1.45 (22.9% Y/Y)... More
